Revelation Biosciences, Inc.
REVB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001810560
No open-market purchases or sales by Revelation Biosciences, Inc. insiders were filed in the last 90 days; 12 institutions reported holding it in 13F filings for Q2 2026, worth $313.2K in total; no superinvestor holds it.
Other share classesREVBW
Q4 2025 vs. Q3 2025
How the institutions holding Revelation Biosciences, Inc. changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Q4 2025 | Change |
|---|---|---|---|
| Holders | 10 | 14 | +4 |
| Shares | 380.1K | 1.23M | +850.9K (+223.9%) |
| Value | $539.7K | $984.3K | +$444.6K (+82.4%) |
New holders (8)
Institutions that held Revelation Biosciences, Inc. at the end of Q4 2025 but not at the end of Q3 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citadel Advisors LLC | 54,728 | $43.8K | 0.00% |
| Vanguard Group Inc | 52,505 | $42.0K | 0.00% |
| Geode Capital Management, LLC | 34,019 | $27.2K | 0.00% |
| Northern Trust Corp | 21,907 | $17.5K | 0.00% |
| HRT Financial LP | 15,320 | $12.0K | 0.00% |
| XTX Topco Ltd | 11,319 | $9.05K | 0.00% |
| Royal Bank of Canada | 2 | $0 | 0.00% |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | 38 | $0 | 0.00% |
Sold out (4)
Institutions that held Revelation Biosciences, Inc. at the end of Q3 2025 and filed for Q4 2025 without it.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| DRW Securities, LLC | 77,272 | $109.7K |
| Jane Street Group, LLC | 14,764 | $21.0K |
| Tower Research Capital LLC (TRC) | 534 | $758 |
| Citigroup Inc | 1 | $1 |